PMID- 28532772 OWN - NLM STAT- MEDLINE DCOM- 20170810 LR - 20170810 IS - 1879-1913 (Electronic) IS - 0002-9149 (Linking) VI - 120 IP - 2 DP - 2017 Jul 15 TI - Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma). PG - 315-321 LID - S0002-9149(17)30712-9 [pii] LID - 10.1016/j.amjcard.2017.04.024 [doi] AB - Change in 6-minute walk distance (6MWD) has been used as a clinical marker in pulmonary hypertension. Determinants and worsening of 6MWD remain a matter of debate because nonpulmonary factors have an impact on the 6MWD. We hypothesized that future reduction of 6MWD in patients with systemic sclerosis (SSc) was more closely associated with cardiac dysfunction. We prospectively performed standard clinical and echocardiographic evaluations in SSc patients with the 6-minute walk test at enrollment. Features associated with the 6MWD were sought in a multiple linear regression analysis and compared using standardized beta. Worsening of the 6MWD was defined as a 15% reduction and served as the primary outcome. Eighty-one patients were included. In the multivariate analysis, baseline 6MWD was related to SSc severity score (beta = -0.250, p = 0.024), left atrial volume index (beta = -0.222, p = 0.046), right ventricular fractional area change (beta = 0.252, p = 0.025), and the ratio of mean pulmonary artery pressure and cardiac output (beta = -0.31, p = 0.002). During follow-up, 20 patients reached the primary outcome. In sequential Cox models, a model based on right ventricular fractional area change at baseline (chi-square 4.8) was improved by left atrial volume index (chi-square 10.3, p = 0.007). In conclusion, determinants and worsening of 6MWD are explained by cardiac factors. When using the 6MWD as a clinical marker in pulmonary hypertension patients, their left ventricular diastolic function and right ventricular systolic function should be taken into consideration. CI - Copyright (c) 2017 Elsevier Inc. All rights reserved. FAU - Kusunose, Kenya AU - Kusunose K AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Yamada, Hirotsugu AU - Yamada H AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. Electronic address: yamadah@tokushima-u.ac.jp. FAU - Nishio, Susumu AU - Nishio S AD - Department of Ultrasound Examination Center, Tokushima University Hospital, Tokushima, Japan. FAU - Hirata, Yukina AU - Hirata Y AD - Department of Ultrasound Examination Center, Tokushima University Hospital, Tokushima, Japan. FAU - Seno, Hiromitsu AU - Seno H AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Saijo, Yoshihito AU - Saijo Y AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Ise, Takayuki AU - Ise T AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Tobiume, Takeshi AU - Tobiume T AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Yamaguchi, Koji AU - Yamaguchi K AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Yagi, Shusuke AU - Yagi S AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Soeki, Takeshi AU - Soeki T AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Wakatsuki, Tetsuzo AU - Wakatsuki T AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. FAU - Sata, Masataka AU - Sata M AD - Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. LA - eng PT - Journal Article DEP - 20170426 PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 SB - IM MH - Diastole MH - Disease Progression MH - Echocardiography, Doppler/*methods MH - Female MH - Follow-Up Studies MH - Humans MH - Hypertension, Pulmonary/*diagnosis/etiology/physiopathology MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - Prospective Studies MH - Scleroderma, Systemic/complications/*diagnosis/physiopathology MH - Stroke Volume/*physiology MH - Systole MH - Time Factors MH - Ventricular Function, Left/*physiology MH - Ventricular Function, Right/*physiology MH - Walking/*physiology EDAT- 2017/05/24 06:00 MHDA- 2017/08/11 06:00 CRDT- 2017/05/24 06:00 PHST- 2017/01/30 00:00 [received] PHST- 2017/04/12 00:00 [revised] PHST- 2017/04/12 00:00 [accepted] PHST- 2017/05/24 06:00 [pubmed] PHST- 2017/08/11 06:00 [medline] PHST- 2017/05/24 06:00 [entrez] AID - S0002-9149(17)30712-9 [pii] AID - 10.1016/j.amjcard.2017.04.024 [doi] PST - ppublish SO - Am J Cardiol. 2017 Jul 15;120(2):315-321. doi: 10.1016/j.amjcard.2017.04.024. Epub 2017 Apr 26.